Believe it or not: how much can we rely on published data on potential drug targets?

Nature reviews. Drug discovery ·Vol. 10 ·No. 9 ·2011-08-31 ·Pages 712

Prinz F, Schlange T, Asadullah K

Abstract

暂无摘要

MeSH Terms

Clinical Trials, Phase II as Topic/statistics & numerical data Drug Design Drug Industry/statistics & numerical data Humans

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Prinz Florian

Schlange Thomas

Asadullah Khusru

References (6)

6 references, click to expand

Why most published research findings are false.
PLoS Med. 2005 Aug;2(8):e124 PMID: 16060722
Fate of submitted manuscripts rejected from the American Journal of Neuroradiology: outcomes and commentary.
AJNR Am J Neuroradiol. 2007 Sep;28(8):1430-4 PMID: 17846185
What happens to the manuscripts that have not been accepted for publication in Occupational and Environmental Medicine?
Occup Environ Med. 2001 Sep;58(9):604-7 PMID: 11511748
Trial watch: Phase II failures: 2008-2010.
Nat Rev Drug Discov. 2011 May;10(5):328-9 PMID: 21532551
What errors do peer reviewers detect, and does training improve their ability to detect them?
J R Soc Med. 2008 Oct;101(10):507-14 PMID: 18840867
Factors affecting reproducibility between genome-scale siRNA-based screens.
J Biomol Screen. 2010 Aug;15(7):735-47 PMID: 20625183

Article Info

Journal

Nature reviews. Drug discovery

Abbr.

Nat Rev Drug Discov

ISSN

1474-1784

DOI

Published

2011-08-31

Epub

2011-00-31

Pages

712

Language

English

Region

England

NLM ID

101124171

Subset

Corrections

CommentOn

PMID: 21532551

External Links

Analysis Services